These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24388541)

  • 1. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.
    Shah N; Parikh V; Patel N; Patel N; Badheka A; Deshmukh A; Rathod A; Lafferty J
    Int J Cardiol; 2014 Feb; 171(3):390-7. PubMed ID: 24388541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
    Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
    Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and reclassification of cardiovascular disease risk.
    Veeranna V; Zalawadiya SK; Niraj A; Pradhan J; Ference B; Burack RC; Jacob S; Afonso L
    J Am Coll Cardiol; 2011 Aug; 58(10):1025-33. PubMed ID: 21867837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST-T wave abnormality in lead aVR and reclassification of cardiovascular risk (from the National Health and Nutrition Examination Survey-III).
    Badheka AO; Patel NJ; Grover PM; Shah N; Singh V; Deshmukh A; Mehta K; Chothani A; Hoosien M; Rathod A; Savani GT; Marzouka GR; Gupta S; Mitrani RD; Moscucci M; Cohen MG
    Am J Cardiol; 2013 Sep; 112(6):805-10. PubMed ID: 23764245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
    Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
    Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-III.
    Badheka AO; Patel N; Tuliani TA; Rathod A; Marzouka GR; Zalawadiya S; Deshmukh A; Moscucci M; Cohen MG
    Am J Med; 2013 Apr; 126(4):319-326.e2. PubMed ID: 23415052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery.
    Larmann J; Handke J; Scholz AS; Dehne S; Arens C; Gillmann HJ; Uhle F; Motsch J; Weigand MA; Janssen H
    BMC Cardiovasc Disord; 2020 May; 20(1):230. PubMed ID: 32423376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.
    Lee HM; Le H; Lee BT; Lopez VA; Wong ND
    Eur Respir J; 2010 Nov; 36(5):1002-6. PubMed ID: 20562119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study.
    Nishimura K; Okamura T; Watanabe M; Nakai M; Takegami M; Higashiyama A; Kokubo Y; Okayama A; Miyamoto Y
    J Atheroscler Thromb; 2014; 21(8):784-98. PubMed ID: 24671110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.
    Merry AH; Boer JM; Schouten LJ; Ambergen T; Steyerberg EW; Feskens EJ; Verschuren WM; Gorgels AP; van den Brandt PA
    Eur J Prev Cardiol; 2012 Aug; 19(4):840-8. PubMed ID: 21551214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic abnormalities improve classification of coronary heart disease risk in women: Tehran Lipid and Glucose Study.
    Hadaegh F; Mohebi R; Bozorgmanesh M; Saadat N; Sheikholeslami F; Azizi F
    Atherosclerosis; 2012 May; 222(1):110-5. PubMed ID: 22385984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults.
    Zalawadiya SK; Gunasekaran PC; Bavishi CP; Veeranna V; Panaich S; Afonso L
    Eur J Prev Cardiol; 2015 May; 22(5):673-9. PubMed ID: 24699336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults.
    Suh B; Shin DW; Kwon HM; Yun JM; Yang HK; Ahn E; Lee H; Park JH; Cho B
    PLoS One; 2017; 12(8):e0183706. PubMed ID: 28829826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM; Weitzman M
    Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.
    Stamatelopoulos K; Sibbing D; Rallidis LS; Georgiopoulos G; Stakos D; Braun S; Gatsiou A; Sopova K; Kotakos C; Varounis C; Tellis CC; Kastritis E; Alevizaki M; Tselepis AD; Alexopoulos P; Laske C; Keller T; Kastrati A; Dimmeler S; Zeiher AM; Stellos K
    J Am Coll Cardiol; 2015 Mar; 65(9):904-16. PubMed ID: 25744007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding multiple risk factors improves Framingham coronary heart disease risk scores.
    Hu G; Root M; Duncan AW
    Vasc Health Risk Manag; 2014; 10():557-62. PubMed ID: 25228812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study.
    Azab B; Chainani V; Shah N; McGinn JT
    Angiology; 2013 Aug; 64(6):456-65. PubMed ID: 22904109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.